Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
about
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic MalignanciesPeriprosthetic hip joint infection with Aspergillus terreus: A clinical case and a review of the literature.Evaluation of Posaconazole Serum Concentrations from Delayed-Release Tablets in Patients at High-Risk for Fungal Infections.
P2860
Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmacokinetics and safety of ...... for invasive fungal infections
@ast
Pharmacokinetics and safety of ...... for invasive fungal infections
@en
Pharmacokinetics and safety of ...... for invasive fungal infections
@nl
type
label
Pharmacokinetics and safety of ...... for invasive fungal infections
@ast
Pharmacokinetics and safety of ...... for invasive fungal infections
@en
Pharmacokinetics and safety of ...... for invasive fungal infections
@nl
prefLabel
Pharmacokinetics and safety of ...... for invasive fungal infections
@ast
Pharmacokinetics and safety of ...... for invasive fungal infections
@en
Pharmacokinetics and safety of ...... for invasive fungal infections
@nl
P2860
P356
P1476
Pharmacokinetics and safety of ...... for invasive fungal infections
@en
P2093
Nathan P Wiederhold
P2860
P356
10.2147/CPAA.S60933
P407
P577
2015-12-23T00:00:00Z